Karolinska Development (investor - Corporate Investor)
Jim Van heusden, Viktor Drvota
B2C (Retail) (4) B2B (4)
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.
6 tracked Nordic investments in:
|Name||Date||Round value||Total raised|
|Modus Therapeutics||Feb 2017||3.59M||3.59M|
* The round values and totals raised are in USD.
** Click on the company for its details and on the round amount for the investment details.